...
首页> 外文期刊>Clinical & developmental immunology. >miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression
【24h】

miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression

机译:MiR-24-3P / FGFR3信号传导作为新型轴涉及上皮 - 间充质过渡并调节肺腺癌进展

获取原文

摘要

Our previous studies showed that Fibroblast growth factor receptor 3 (FGFR3) contributed to cell growth in lung cancer. However, the correlation between FGFR3 and tumor progression, coupled with the underlying mechanisms, are not fully understood. The clinical significance of FGFR3 was determined in two cohorts of clinical samples ( n = 22, n = 78). A panel of biochemical assays and functional experiments was utilized to elucidate the underlying mechanisms and effects of FGFR3 and miR-24-3p on lung adenocarcinoma progression. Upregulated FGFR3 expression indicated an adverse prognosis for lung adenocarcinoma individuals and promoted metastatic potential of lung adenocarcinoma cells. Owing to the direct regulation towards FGFR3, miR-24-3p could interfere with the potential of proliferation, migration, and invasion in lung adenocarcinoma, following variations of EMT-related protein expression. As a significant marker of EMT, E-cadherin was negatively correlated with FGFR3, of which ectopic overexpression could neutralize the antitumour effects of miR-24-3p and reverse its regulatory effects on EMT markers. Taken together, these findings define a novel insight into the miR-24-3p/FGFR3 signaling axis in regulating lung adenocarcinoma progression and suggest that targeting the miR-24-3p/FGFR3 axis could be an effective and efficient way to prevent tumor progression.
机译:我们以前的研究表明,成纤维细胞生长因子受体3(FGFR3)有助于肺癌的细胞生长。然而,FGFR3与肿瘤进展之间的相关性,与潜在机制相结合,不完全理解。 FGFR3的临床意义在临床样品的两个群组中测定(n = 22,n = 78)。利用生物化学测定和功能实验面板来阐明FGFR3和MIR-24-3P对肺腺癌进展的潜在机制和影响。上调的FGFR3表达表明肺腺癌个体的不良预后,促进肺腺癌细胞的转移潜力。由于对FGFR3的直接调节,MIR-24-3P可能会干扰肺腺癌中的增殖,迁移和侵袭的潜力,这是肺腺癌中的扩散,迁移和侵袭,术后蛋白表达的变化。作为EMT的显着标记,E-Cadherin与FGFR3负相关,其中异位过表达可以中和miR-24-3p的抗肿瘤作用,并逆转其对EMT标记的调节作用。总之,这些发现将新颖的洞察力定义了对MiR-24-3P / FGFR3信号轴进行调节肺腺癌进展,并表明靶向MIR-24-3P / FGFR3轴可能是一种有效且有效的方法来防止肿瘤进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号